Understanding how embryos communicate with their cells using chemical signals
Decoding the Spatial Grammar of Developmental Signaling
['FUNDING_OTHER'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10687505
This study is exploring how embryos use chemical signals to guide their cells, and it's designed to help scientists learn how to better direct stem cells to grow into specific tissues, which could eventually lead to new ways to create replacement tissues for medical treatments.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10687505 on ClinicalTrials.gov |
What this research studies
This research investigates the complex language of chemical signals that embryos use to instruct their cells. By developing new methods to create and test these signaling patterns, the project aims to enhance our understanding of how stem cells can be guided to form specific tissues. The approach utilizes high-throughput optogenetic manipulation, allowing researchers to control and observe signaling patterns in human stem cells with high precision. This innovative methodology could lead to breakthroughs in regenerative medicine by enabling the creation of replacement tissues in the lab.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in advancements in regenerative medicine, particularly those with conditions requiring tissue replacement or repair.
Not a fit: Patients with conditions unrelated to tissue regeneration or those not seeking experimental therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could revolutionize regenerative medicine by providing new ways to create and manipulate tissues for therapeutic purposes.
How similar studies have performed: Other research has shown promise in using optogenetic methods for manipulating cellular processes, indicating potential success for this novel approach.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LORD, NATHAN DALE — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: LORD, NATHAN DALE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.